Skip to main content

Top vaccine makers Merck and Pfizer target China and older adults next

Four giant companies now dominate global vaccine sales. With newer and more expensive vaccines becoming available, the market value of vaccines could rise to $100 billion by 2025.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.